Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma

This study has been completed.
CTI BioPharma
Information provided by:
Stanford University Identifier:
First received: September 12, 2005
Last updated: April 8, 2009
Last verified: April 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2009
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)